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ABSTRACT
LI 210 cells were selected for resistance to the ornithine decarboxylase
(ODC) inhibitor, a-difluoromethylornithine. When grown in the absence
of the inhibitor, these cells possessed very high ornithine decarboxylase
levels. These represented about 1 part in 300 of the soluble protein,
which is several hundred times greater than the maximal value found in
the original 11210 cells. The resistant cells contained at least 100-fold
higher levels of ODC mRNA but the half-life of ODC (about 45 min)
was not altered significantly. The resistant cells had much higher putres-
cine and cadaverine levels than control cells, but there was no significant
difference in cellular spermidine or spermine content or in production of
S'-methylthioadenosine, which is a measure of polyamine synthesis.
Addition of putrescine to the control or resistant cells had no effect on
their content of spermidine and spermine but addition of decarboxylated
5-adenosylmethionine increased the content of spermidine and spermine.
These results indicate that ornithine decarboxylase is not the rate-limiting
step in polyamine synthesis in these 1.121(1cells.
The growth of the a-difluoromethylornithine-resistant LI 210 cells was
inhibited when their ability to synthesize spermidine and spermine was
blocked by the addition of the 5-adenosylmethionine decarboxylase in
hibitor, 5'-deoxy-5'-|yV-methyl-yV-(3-hydrazinopropyl)]aininoadenosine.
Treatment with this compound produced a reduction of more than 85%
in the production of 5'-methylthioadenosine and led to a large increase
in the content of putrescine and a substantial decline in the content of
spermidine and spermine. These results indicate the potential value of .V-
adenosylmethionine decarboxylase inhibitors as therapeutic agents in
conditions where ODC inhibitors are ineffective.
INTRODUCTION
Polyamines appear to be essential for the normal growth and
development of mammalian cells and there has been consider
able recent interest in the possibility that substances interfering
with the synthesis of polyamines may be useful antitumor agents
(1-5). Most of these inhibitors have been directed against the
activity of ODC3 and many studies have shown that the block
ade of ODC activity has an antiproliferative effect. Much of
this work has been carried out with the enzyme-activated irre
versible inhibitor, DFMO and this compound clearly has po
tential as a therapeutic agent (6-8). However, there have been
several reports of the emergence of DFMO-resistant cells in
cultures exposed to this drug for a long period of time (9-16).
Such resistance has usually, but not always (5, 12, 13), been
associated with amplification of the ODC gene and consequent
overproduction of ODC. The cell lines containing such ampli
fied genes have been useful tools for molecular biological studies
of ODC (9, 10) but there has been little attention given to the
actual properties of the DFMO-resistant cells in terms of pol
yamine metabolism and sensitivity to alternative inhibitors
Received 11/30/87; revised 2/8/88; accepted 2/16/88.
The costs of publication or this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked advertisement in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1This work was supported by Grants CA-18138, CA-37606, GM-26290, and
NOl-AI-42555fromNIH.
2To whom requests for reprints should be addressed, at Department of
Physiology, Milton S. Hershey Medical Center, Pennsylvania State University,
P. O. Box 850, Hershey, PA 17033.
3The abbreviations used are: ODC, ornithine decarboxylase; DFMO, a-difluo-
romethylornilhine; MHZPA, 5'-deoxy-5'-[Af-methyl-/V-(3-hydrazinopropyl))ami-
noadenosine; D-R, DFMO-resistanl LI 210 cells; MIA, S'-methylthioadenosine.
affecting other steps in the polyamine biosynthetic pathway. In
the present work, we have derived a line of LI210 cells that is
highly resistant to DFMO because of a very high content of
ODC. The consequences with regard to polyamine metabolism
of this overproduction, which appears to be stable in the absence
of the drug, have been evaluated. Also, the effects of a potent
inhibitor of S-adenosylmethionine decarboxylase on these cells
have been examined. The results indicate that ODC is not the
rate-limiting step in spermidine and spermine production by
LI210 cells and that the proliferation of the D-R L1210 cells
can be inhibited by blocking the activity of S-adenosylmethio-
nine decarboxylase.
MATERIALS AND METHODS
Assay of Ornithine Decarboxylase Activity and mRNA Content. ODC
activity was measured by measuring the release of I4CO2from L-[1-'4C]
ornithine as described by Seely et al. (17). ODC protein was determined
by radioimmunoassay (18). The content of ODC mRNA was deter
mined by Northern and dot blot analysis using published methods for
RNA extraction and hybridization with a cDNA probe for mouse ODC
(19, 20). The half-life of ODC was measured after inhibition of protein
synthesis by cycloheximide using the procedures described by Pegg et
al. (21).
Cell Culture. Control LI210 cells were maintained and grown in
suspension culture in RPMI 1640 medium containing 10% Nu Serum
(Collaborative Research, Inc., Lexington, MA) as described by Pera et
al. (22). The DFMO-resistant cells were obtained by growing the cells
in increasing concentrations of DFMO starting with 0.2 mM and
proceeding through 0.5, 1,5, 10, and 20 mM. The cells were maintained
at each concentration of DFMO until their growth rate increased to
that of the control cells without DFMO. The entire selection period
was about 4 months. Cells were cloned by limiting dilution. Some of
the experiments shown were carried out with the cells that were ob
tained after the 10 HIM DFMO selection. The further selection by
increasing the drug concentration to 20 mM DFMO did not produce
cells having significantly greater levels of ODC.
Analysis of Diamines, Polyamines, and 5'-Methylthioadenosine. The
cells were then harvested and extracts prepared for polyamine analysis
as described (21). Appropriate aliquots of these extracts were used for
the determination of intracellular putrescine, cadaverine, and poly
amines. Aliquots of the cell culture medium were deproteinized by the
addition of an equal volume of 10% perchloric acid followed by cen-
trifugation to remove the protein. These aliquots were used to determine
the excretion of putrescine, cadaverine, and polyamines by the cultures.
The production of S'-methylthioadenosine was measured using the
same extracts and the same HPLC separation system.
Analysis was carried out using using an ion-pair reversed-phase
separation (23). The content of putrescine, cadaverine, spermidine, and
spermine was determined by post-column derivatization with o-phthal-
aldehyde (24). Intracellular diamines and polyamines were expressed
as nmol/culture or as nmol/mg protein. Protein was determined by the
method of Bradford (25). Extracellular polyamines were expressed as
nmol/culture.
In order to determine S'-methylthioadenosine, the eluate was moni
tored at 254 nm and the amount calculated from the peak heights using
standard curves constructed with the authentic compounds. The
amount of S'-methylthioadenosine was expressed as nmol/culture.
Materials. L-[l-14C]ornithine (55 Ci/mol) was purchased from NEN,
Boston, MA. All biochemical reagents were obtained from the Sigma
Chemical Co., St. Louis, MO. DFMO was a generous gift from Dr. P.
2678
PROPERTIES OF L1210 CELLS RESISTANT TO DFMO
Table 1 Ornithine decarboxylase activities in control and D-R LI210 cells
Results are shown as mean Â±SD for more than three estimations.
ODC activity(units/mgprotein)"Hours624304872Controlcells12.3
Â±0.622.4
Â±818.3
Â±0.810.0
Â±1.23.5
Â±1.1D-R
cells2254
Â±3264349
Â±9945150Â±9193671
Â±2461782
Â±95mRNA
content(units/jigRNA)*ControlcellsNDr1
Â±0.3ND0.8
Â±0.2NDD-R
cellsND120
Â±25ND130
Â±30ND
" A unit of ODC activity produces 1 nmol of 14CO2in 60 min.
* The mRNA content was determined by scanning of Northern and dot blots
with a densitometer and is expressed in arbitrary units which were set at 1 for the
control cell RNA.
' ND, not determined.
P. McCann, Merrell Dow Research Institute, Cincinnati. MHZPA was
synthesized by Secrist et al.4 Plasmid pODC934, which contains an
insert complementary to ODC mRNA, was a gift from Dr. F. G.
Berger, University of South Carolina, Columbia, SC.
RESULTS
ODC Level of DFMO-resistant LI 210 Cells. It is well known
that DFMO at 1-5 HIMgreatly reduces the growth of L1210
cells (2, 22) and this effect was reproduced in our laboratory.
Resistance to inhibitor was induced by growing the cells in
increasing concentrations of DFMO with the cells maintained
at each concentration until a normal growth rate was obtained.
The cells increased their ODC activity as they acquired resist
ance to DFMO. When the resistant cells were grown in the
absence of DFMO, the ODC activity 6 h after the addition of
serum was 25 Â±4 units/mg for the cells resistant to 0.2 HIM,
261 Â±82 units/mg for cells resistant to l IHM,2322 Â±393 for
cells resistant to 5 mM and 2575 Â±458 for cells resistant to 10
HIMDFMO.
The final D-R cell line grew at a rate similar to the control
cells in the absence of the inhibitor but was unaffected by the
presence of DFMO at concentrations of up to 20 mM. When
grown in the absence of DFMO, the D-R cells had very high
levels of ODC (Table 1) that were 200-400 times greater than
in the control cells grown under the same conditions. This
increase was entirely due to an increased amount of ODC
protein rather than any change in its catalytic activity since
measurements of the protein by radioimmunoassay gave iden
tical results to the activity measurements (results not shown).
Despite the greatly increased content of ODC protein, its half-
life was not significantly altered in the D-R cells. The half-life
was 41 min in the control cells and 50 min in the treated cells.
A substantial part, and possibly all of the increase in ODC
protein, was due to an increased content of the mRNA. The
ODC mRNA present in these cells was analyzed on Northern
blots using a nick-translated cDNA probe and it was found to
consist of a major species of about 2.2 kilobases and a faint
minor species of 2.6 kilobases (results not shown). These sizes
are in agreement with previous estimates of size of the ODC
mRNA in LI 210 cells (19). The increase in the level of mRNA
was at least 100-fold as measured by densitometric scanning of
Northern blots and dot blots (Table 1). This procedure for
estimating the increase in mRNA content is not sufficiently
accurate to be certain whether the change in mRNA is the sole
factor responsible for the increase in ODC but it is clearly the
major component in this increase.
Diamine, Polyamine, and 5'-MethyIthioadenosine Content of
D-R Cells. Analysis of the polyamine content of the D-R cells
and the control cells grown in the absence of DFMO revealed
a number of interesting differences. Firstly, the D-R cells, which
have very high ODC levels, contained much higher amounts of
putrescine and also contained cadaverine, which was not de
tected in the control cells (Table 2). Secondly, the medium from
these DFMO-resistant cells contained large amounts of putres
cine and cadaverine (Table 2). There was no significant differ
ence in the spermidine and spermine content between the two
cell lines (Table 2). Spermine and spermidine were not present
in the medium in detectable concentrations.
These results show that, despite the much greater level of
ODC in the DFMO-resistant cells, they do not form greater
amounts of the polyamines, spermidine, and spermine. It could
be argued that these polyamines are made in larger quantities
and are then degraded but this possibility is ruled out by the
measurement of MTA levels in the culture medium. As shown
in Table 2, there was no difference in the production of MTA
by the two cell lines. MTA is formed in the spermidine synthase
and spermine synthase reactions and it is known that the LI 210
cells used in these experiments do not degrade MTA but excrete
it into the medium (1-3, 26-28). Thus, the production and
excretion of MTA is a measure of the total extent of polyamine
biosynthesis in these cells.
Effect of Addition of DFMO, Putrescine, or Decarboxylated
S-Adenosylmethionine on Amine Content in Control and D-R
Cells. The addition of 10 mM DFMO to control LI210 cells
led to an inhibition of growth and to the reduction of cellular
putrescine and spermidine to undetectable levels (Table 3).
Addition of 10 mM DFMO to the D-R cells led to a striking
decrease in putrescine and spermidine but the residual levels
still amounted to 22 and 45% of the amounts found in the
control LI210 cells and growth was not affected.
The addition of 100 MMputrescine to control or D-R cells
increased intracellular putrescine but had no effect on spermi
dine and spermine (Table 3). These results also suggest that the
supply of putrescine is not the limiting factor in the production
of polyamines in LI 210 cells. In contrast, the addition of 100
MMdecarboxylated S-adenosylmethionine led to a significant
increase in the content of both spermidine and spermine in
LI210 cells and in the D-R cells. The increase in spermine in
Table 2 Polyamine and MTA levels in D-R and control cells
Intracellular content of diamines and polyamines
(nmol/culture)
Cells-Control
D-R
Control
D-R
Control
DRTime
(h)30
30
48
487272Putrescine1.0
Â±0.1
6.4 Â±0.6
2.5 Â±0.6
17.4 Â±1.1
10.8 Â±1.0
83.6 Â±11.1Spermidine4.6
Â±0.65.5
Â±0.4
17.3 Â±1.7
22.5 Â±1.5
77.2 Â±5.2
70.8 Â±9.3Spermine1.9
Â±0.2
1.5Â±0.25.5
Â±0.6
5.0 Â±0.9
21.9 Â±2.9
17.6 Â±0.8Cadaverine<1
1.4 Â±0.2
<1
6.1 Â±0.7
<1
18.1 Â±1.4
Diamines and MTA in medium (nmol/cul
ture)*
Cells"Control
D-R
Control
D-R
Control
D-RTime
(h)30
30
48
487272Putrescine1.7
+ 0.2
10.4+ 1.7
2.3 Â±0.9
21.2 Â±2.9
5.2+ 1.7
89.1 + 16.5Cadaverine6.7
Â±0.8
1.6 Â±0.2
29.1 Â±5.7
1.1 Â±0.2
71.2 + 14MTA7.5
+ 2.3
9.1 Â±1.8
26.6 Â±2.9
30.6 Â±1.1
94.2 Â±2.6
101.3 + 7.8
" J. A. Secrist HI, W. B. Forrister, T. H. Moss, E. L. White, and W. M.
Shannon. Synthesis of substrate-analogue inhibitors of 5-adenosylmethionine
decarboxylase, manuscript in preparation.
" The control and the DFMO-resistant cells grew at the same rate and there
was no significant difference between them in the cell number at any time of
culture. These numbers were 1.2 x 105/ml, 3.5 x 10'/ml, and 14 x lO'/ml at 30,
48, and 72 h, respectively.
* Results are shown as mean Â±SD for more than three estimations.
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Table 3 Effect ofpulrescine and decarboxylaled AdoMet on polyamines in
control and D-R L1210 cells
Results are shown as mean Â±SD for more than three estimations.
Polyamine levels (nmol/mg protein)
Cell and treatment" Putrescine Spermidine Spermine
ControlControl
+ 10 mMDFMOControl
t KKIÂ«MdecarboxylatedAdo etControl
+ 100 /IMputrescineD-RDR
-H10 mMDFMOD-R
* 100 ,,MdecarboxylatedAdoMetD-R
+ 100 /IM putrescine3.9
Â±1.1<0.13.0
Â±1.37.4
Â±0.819.1
Â±2.70.9Â±0.1*9.2
Â±0.480.2
+ 5.123.9
Â±2.1<0.131.6
Â±6.925.1
Â±1.722.5
Â±5.413.1
Â±0.629.1
Â±2.222.6
Â±5.38.3
Â±1.39.6
Â±1.412.3
Â±1.56.1
Â±0.39.6
Â±2.47.1
Â±0.924.7
Â±6.87.6
Â±1.6
" Measurements were made after 40 h of culture in the presence of the
compounds shown.
* All of the putrescine present in the medium of D-R cells (see Table 2) was
abolished by the presence of 10 mM DFMO.
Table 4 Effect of MHZPA on MTA production in control and D-R cells
Results are shown as the mean for three estimations.
S'-Methylthioadenosine content (numi ml culture)
ControlcellsTreatment
<h)4872No addition2.36
7.95+
SOjiM
MHZPA0.36
1.0DFMO
resistantcellsNo
addition2.20
7.19+
50)iM
MHZPA0.32
0.72
Table 5 Effect of 50 Â¡MMHZPA on polyamines in D-R LI210 cells
Results shown are the mean Â±SD for four or more estimations or the mean
of three estimations.
Polyamine levels (nmol/mg protein)
Cell andtreatmentD-RD-R
+MHZPAD-RD-R
+MHZPAD-RD-R
+MHZPAControlControl
+ MHZPATime
(h)2424484872724848Putrescine31.6110.224.9
Â±3.272.6
Â±6.334.4128.72.3
Â±0.226.1
Â±7.7Spermidine27.011.229.8
Â±3.69.6
Â±1.530.95.527.2
Â±2.011.3
Â±3 5Spermine6.81.87.5
Â±1.61.15.9<I7.5
Â±1.42.9
Â±0.8
the D-R cells in response to decarboxylated 5-adenosylmethio-
nine was particularly striking (2.6-fold).
Effect of Inhibition of S-Adenosylmethionine Decarboxylase
in D-R Cells. The effects of MHZPA, an inhibitor of 5-adeno-
sylmethionine decarboxylase (28,29), on polyamine production
and the growth of the D-R cells were examined. As shown in
Table 4, the addition of MHZPA to either the control cells or
to the D-R cells led to a more than 90% inhibition of the
production of MTA indicating that this inhibitor does effec
tively block polyamine synthesis in these cells. Analysis of the
polyamine content in the cells showed that MHZPA caused a
large drop in the content of spermine, a significant but slightly
smaller decline in the content of spermidine and a massive
increase in the content of putrescine (Table 5). The putrescine
content in the D-R cells, which was already about eight times
greater than in the control cells, was increased another 3- to 4-
fold by the presence of MHZPA. These results are consistent
with the blockage of the polyamine biosynthesis pathway by
MHZPA at the .S-adenosylmethionine decarboxylase step.
The addition of MHZPA to the control LI 210 cells led to a
decreased rate of cell growth (Table 6). This decrease in growth
was similar to that produced by 5 HIM DFMO. As expected,
DFMO had no effect on the growth of the D-R cells but their
growth was inhibited by MHZPA to the same extent as that of
the control cells (Table 6). The addition of 5 MMspermidine
Table 6 Effect of DFMO and MHZPA on growth of LI 210 cells and
D-R L1210 cells
Results are shown as mean Â±SD for live estimations.
Cell number" (% control)
Cells andtreatmentControl
D-R
Control + 5 mM DFMO
D-R -1-5 mM DFMO
Control -I-50 Â»IMHZPA
D-R + 50 MMMHZPA24
h100
97 Â±8
76 Â±11
105 Â±13
78 Â±3
83 Â±1248
h100
106Â± 12
47 Â±6
101 Â±1947
Â±5
42 Â±572
h100
95 Â±9
19 Â±4
98 Â±2
21 Â±3
24 Â±6
" The actual control cell numbers were 0.9, 3.4, and 16 (x IOVinl) at these time
points and the cells had a doubling time of 10.8 h.
reversed the growth-inhibitory action of MHZPA on the D-R
L1210 cells (results not shown).
DISCUSSION
The very high ODC activity found in the D-R cells when
grown in the absence of the inhibitor corresponds to an ODC
content of about one part in 200-400 of the total soluble
protein. The ODC mRNA represents about 3.6% of the total
mRNA in these D-R cells. [This was quantitated by comparing
dot blots using a standard curve of authentic ODC mRNA
synthesized in vitro from a plasmid containing a cDNA insert
to ODC (30).] These cells are therefore comparable, or in some
cases more active, in production of ODC to other DFMO-
resistant cells that have been derived in several different labo
ratories (9-16). Although we have not checked this specifically,
it is likely that the major cause of the increased production of
ODC mRNA is gene amplification. The high level of ODC
production in our D-R cells appears to be stable in the absence
of DFMO and the large amount of ODC does not exert adverse
effects on the rate of cell growth. These properties should render
the cell lines particularly useful for studies of the regulation
and function of ODC. It is particularly interesting that the rapid
turnover of ODC protein is not affected in these cells. This
suggests that any factors needed for the physiological degrada
tion of the enzyme are either present in great excess or are
increased coordinately with the ODC protein.
Overproduction of ODC leading to DFMO resistance has
now been reported by a number of investigators and appears to
be a relatively common phenomenon when a normal rate of
cell growth is prevented by means of this inhibitor. Several
groups have shown that the increased production of ODC
provides a means by which some polyamines can be synthesized
even in the presence of the inhibitor (11-16) but there have
been no prior detailed studies of the consequences of the over
production of ODC when the inhibitor is not present. Our
finding of the presence of cadaverine in these cells is not entirely
surprising since it is known that ODC will decarboxylate lysine
although lysine is a much poorer substrate than ornithine (31,
32). Cadaverine is therefore only found in significant amounts
in mammalian tissues, such as the mouse kidney, where ODC
activity is very high (31). Lysine is present in quite large
amounts in the RPMI medium used for the LI210 cells, and it
is unlikely that it would become depleted by this reaction.
However, it is possible that, under other culture conditions, the
conversion of lysine to cadaverine by excess ODC could influ
ence growth by reducing the availability of this essential amino
acid.
It is clear from the results in Table 2 that, despite the very
high content of putrescine in the D-R cells, there was no
increase in the cellular content of spermidine and spermine.
The possibility that excess of these polyamines are actually
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made but are then degraded or excreted is ruled out by the
findings that there was no spermidine or spermine in the
medium and that 5'-methylthioadenosine excretion was also
not different between the control and the D-R cells. Since ODC
activity is several hundred times greater in the D-R cells than
in the control cells this finding provides strong evidence that
the activity of ODC is not the rate-limiting factor in spermidine
and spermine production by these LI210 cells. This conclusion
is reinforced by the results of the addition of putrescine or
decarboxylated S-adenosylmethionine to the cells. Putrescine
had no effect on the polyamine content but provision of decar
boxylated S-adenosylmethionine increased the amount of sper
midine and spermine. This implies that the activity of .V-
adenosylmethionine decarboxylase is the rate-limiting factor in
the biosynthesis of polyamines in these cells. The very large
increase in spermine seen in the D-R cells after the addition of
decarboxylated S-adenosylmethionine is consistent with this
interpretation since, once the aminopropyl donor has been
provided, the excess of putrescine can be converted through
spermidine into spermine that is the end-point of the pathway.
It should be noted that the original LI210 cells have quite
high ODC activities and this conclusion concerning the rate-
limiting factor may not apply to all other mammalian cell types.
It is possible that in other cell types the excess production of
spermidine and spermine in response to a high level of ODC
expressed when DFMO is removed from a DFMO-resistant
cell line may actually lead to a toxic effect. Excretion of excess
polyamines or their degradation to putrescine by the poh am ine
W-acetyltransferase/oxidase system (1, 33) may be necessary
to prevent this. In our experiments with the D-R LI210 cells,
where only the diamines were produced in excess, at least 50%
of the putrescine and more than 75% of the cadaverine that
was formed was excreted into the medium. Even the control
L1210 cells were found to excrete putrescine (Table 2) although
the amount released was much less than from the D-R LI210
cells. This finding, and the fact that addition of exogenous
putrescine did not alter cellular spermidine content (Table 3
and Reference 34) are also consistent with the ODC step not
being rate determining for spermidine synthesis in LI210 cells.
The D-R L1210 cells were found to be highly sensitive to the
5-adenosylmethionine decarboxylase inhibitor, MHZPA (28,
29). This compound prevented the production of spermidine
and spermine and led to a rise in putrescine above the already
very high content present in these cells. MHZPA also blocked
the growth of the cells as shown in Table 6. These findings
strongly support the hypothesis that putrescine cannot fulfill
the functions of spermidine and spermine that are needed for
LI210 cell growth even when it is present in very high concen
trations. They also indicate that it is possible that tumor cells
resistant to ODC inhibitors by virtue of an increased content
of ODC may easily be controlled by inhibitors of other steps in
the pathway. These include MHZPA and other S-adenosylme-
thionine decarboxylase inhibitors (5, 28, 29) and possibly the
aminopropyltransferase inhibitors (5, 35). Another approach
would be to use the bis(alkyl)polyamines described by Porter
and Bergeron and colleagues (2, 19, 36, 37) that repress both
ODC and S-adenosylmethionine decarboxylase activities.
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